Gain Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2024 | 2 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q4 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Gain Therapeutics, Inc. Earnings Date And Information
Gain Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.42 earnings per share for the quarter, missing analysts' consensus estimates of $-0.31 by $0.11. The company had revenue of 0 for the quarter and had revenue of 55,180 for the year. Gain Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.71 diluted earnings per share) and currently has a price-to-earnings ratio of -2.17. Gain Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Gain Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.17 | $10,000 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.31 | -$0.42 | -0.11 | $400,000 | $0 |
| 05/14/2024 | Q1 2024 | -$0.30 | -$0.22 | 0.08 | $0 | |
| 03/26/2024 | Q4 2023 | -$0.32 | -$0.29 | 0.03 | $64,800 | |
| 11/14/2023 | Q3 2023 | -$0.47 | -$0.37 | 0.1 | $337,500 | $0 |
| 08/10/2023 | Q2 2023 | -$0.33 | -$0.62 | -0.29 | $1.01 M | $0 |
| 05/12/2023 | Q1 2023 | -$0.40 | -$0.43 | -0.03 | $55,180 | |
| 03/23/2023 | Q4 2022 | -$0.37 | -$0.39 | -0.02 | $140,108 | |
| 11/10/2022 | Q3 2022 | -$0.46 | -$0.38 | 0.08 | $51,500 | $0 |
| 08/08/2022 | Q2 2022 | -$0.35 | -$0.43 | -0.08 | $31,667 | $95,102 |
| 05/16/2022 | Q1 2022 | -$0.34 | -$0.28 | 0.06 | $45,006 | |
| 03/25/2022 | Q4 2021 | -$0.32 | $36,341 | |||
| 11/12/2021 | Q3 2021 | -$0.34 | -$0.39 | -0.05 | $20,000 | $27,345 |
| 08/12/2021 | Q2 2021 | -$0.30 | $89,173 | |||
| 05/10/2021 | Q1 2021 | -$0.21 | -$0.50 | -0.29 | $5,269 | |
| 12/31/2020 | Q4 2020 | -$0.15 | $9,139 | |||
| 09/29/2020 | Q3 2020 | -$0.30 | $6,696 | |||
| 06/29/2020 | Q2 2020 | -$0.20 | $6,373 | |||
| 03/30/2020 | Q1 2020 | -$0.22 | $6,673 | |||
| 12/30/2019 | Q4 2019 | -$0.32 | $0 |
Gain Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Gain Therapeutics, Inc.'s earnings date?
Gain Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Gain Therapeutics, Inc.'s earnings conference call?
The conference call for Gain Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Gain Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Gain Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Gain Therapeutics, Inc. generate each year?
Gain Therapeutics, Inc. (:GANX) has a recorded annual revenue of $55,180.
-
How much profit does Gain Therapeutics, Inc. generate each year?
Gain Therapeutics, Inc. (:GANX) has a recorded net income of $55,180. Gain Therapeutics, Inc. has generated $-1.71 earnings per share over the last four quarters.
-
What is Gain Therapeutics, Inc.'s price-to-earnings ratio?
Gain Therapeutics, Inc. (:GANX) has a price-to-earnings ratio of -2.17 and price/earnings-to-growth ratio is -0.16.
